The AJT report: news and issues that affect organ and tissue transplantation. Wrestling with positive cross-matches. A look at some of the newer desensitization therapies.
Pondrom
Sue
S
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived; D001897:Boronic Acids / Q000627:therapeutic use; D000069286:Bortezomib; D003888:Desensitization, Immunologic / Q000379:methods*; D006084:Graft Rejection / Q000517:prevention & control; D006650:Histocompatibility Testing; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007165:Immunosuppression Therapy / Q000379:methods; D010956:Plasmapheresis; D011719:Pyrazines / Q000627:therapeutic use; D000069283:Rituximab; D014181:Transplantation Immunology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived; D001897:Boronic Acids; D016756:Immunoglobulins, Intravenous; D011719:Pyrazines; D000069283:Rituximab; D000069286:Bortezomib; C481642:eculizumab